This insider cluster is too small to signal a change in business outlook. Monitor upcoming pipeline catalysts (e.g., bitopertin or DISC-0974 data) for fundamental direction; insider activity alone does not warrant a trade.
IRON drugs
IRON drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 15 $76.02entry
- T+1 · 4mo ago −3.35%α −2.81% · $73.47
- T+5 · 4mo ago −2.24%α −1.26% · $74.32
- T+20 · 3mo ago +6.01%α +3.67% · $80.59
- T+60 · 6w ago −20.06%α −22.59% · $60.77
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two insiders at Disc Medicine (CEO and COO) sold a combined $729K in open-market shares over a one-week window. The total value is less than 0.03% of the company's $2.9B market cap, making this cluster economically trivial and routine. The CEO's sales followed option exercises, consistent with typical tax/diversification planning, and the COO's sale was negligible.
Key Financial Metrics
Key Facts
- CEO John Quisel sold 9,700 shares at $74.27 for $721K on 2026-07-13
- COO Jonathan Yen-Wen Yu sold 100 shares at $82.50 for $8K on 2026-07-07
- Total open-market sales of $729K represent ~0.025% of IRON's $2.9B market cap
- CEO also exercised 32,000+ options (non-cash) on the same day, a common pattern for share settlement
Financial Impact
Insider sales of $729K are immaterial relative to $2.9B market cap
Risk Factors
- No material risk from this filing; the cluster is routine and non-informative
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-IRON-1784068362255 |
Track record
43 reports on IRON
7 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +20.07% at T+20 after the Sep 3, 2026 report. 11 of 16 went positive at some point.
Filters
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $87.08 Now $76.59 −12.05% settles Dec 10
- Nov 5, 202611d ago 424B5 Bearish 5/10 Entry $78.91 Now $76.59 +2.94% settles Dec 7
- Nov 5, 202611d ago 8-K Neutral 5/10 No price data
- Nov 5, 202611d ago Press Release Bullish 7/10 Entry $78.47 Now $76.59 −2.40% settles Dec 4
- Nov 4, 202612d ago Press Release Neutral 3/10 Entry $83.28 Now $76.59 −8.03% settles Dec 3
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $81.16 Now $76.59 −5.63% settles Dec 2
- Oct 26, 202621d ago SC 13D/A Neutral 3/10 Entry $79.90 Now $76.59 −4.14% settles Nov 24
- Oct 22, 202625d ago 8-K Bearish 6/10 Entry $74.51 Now $76.59 −2.79% settles Nov 20
- Oct 21, 202626d ago 424B5 Bearish 6/10 Entry $75.03 Now $76.59 −2.08% settles Nov 19
- Oct 21, 202626d ago 144 Neutral 2/10 Entry $75.03 Now $76.59 +2.08% settles Nov 19
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers